A full-service CRO across Central and Eastern Europe, the Baltics, the Caucasus and Central Asia
A full-service clinical research organisation delivering phase I–IV trials, medical device investigations and bioequivalence studies. Founded in Georgia in 2015, with a United Kingdom entity since 2023.
Client feedback
“The entire Clinical Operations team has proven to be highly responsive and compliant, providing effective and timely support throughout the project — smooth, professional and solution-oriented.”
“Regulatory support and monitoring were always performed with great attention to detail, within agreed timelines. What stands out is responsiveness, proactive communication and a strong sense of ownership.”
“Enrolment goals were met at the assigned sites and documentation quality remained strong. Paspigioni would very likely be our partner of choice for future opportunities in Georgia.”
What we do
Clinical trials, phase I to IV
Interventional trials in 44 indications, from first-in-human and healthy-volunteer studies through to large phase III programmes.
Medical device investigations
Clinical investigations under ISO 14155 across cardiovascular, orthopaedic, surgical, urological and wearable devices — including studies registered on ClinicalTrials.gov.
Bioequivalence studies
Study design, regulatory strategy, biowaiver justification, clinical conduct and an eCTD-ready dossier. EU-submission oriented, with bioanalysis at GLP-certified partner laboratories.
Non-interventional and investigator-initiated studies
Observational and post-authorisation studies, registries, and operational and regulatory support for investigator-initiated research.
Why us
Senior people on your study
The people who win the work run the work. Our CEO, Operations Director and Director of Clinical Operations are all physicians, and all are personally involved in delivery.
Patients you cannot reach in Western Europe
Largely treatment-naïve populations, short referral chains and investigators who are not competing with twenty other trials for the same patients.
Start-up in weeks, not quarters
Country submissions run in parallel rather than in sequence. Our last multi-country programme went from core pack to first patient in five countries in four months.
Regulatory knowledge that is local
Our own regulatory specialists submit in each country, in the local language, with the local notarisation and import-licence requirements already known.
No non-billable charges
Administrative and non-billable tasks are not charged to your study budget. Unit-based, milestone-based and FTE models are all available.
A decade of CRO-grade scrutiny
63 studies delivered inside the programmes of global and mid-size CROs, each of which qualified us as a vendor before contracting.
News
Latest news from Paspigioni
Conferences, webinars, new countries and team news — posted first on our LinkedIn page.
Member of EUCROF and the BioIndustry Association.